???pagination.result.count???
???pagination.result.page???
1
DNA2 and EXO1 in replication-coupled, homology-directed repair and in the interplay between HDR and the FA/BRCA network. , Karanja KK, Cox SW, Duxin JP , Stewart SA, Campbell JL ., Cell Cycle. November 1, 2012; 11 (21): 3983-96.
Xenopus DNA2 is a helicase/nuclease that is found in complexes with replication proteins And-1/ Ctf4 and Mcm10 and DSB response proteins Nbs1 and ATM. , Wawrousek KE, Fortini BK, Polaczek P, Chen L, Liu Q, Dunphy WG , Campbell JL ., Cell Cycle. March 15, 2010; 9 (6): 1156-66.
Identification of a functionally important negatively charged residue within the second catalytic site of the SUR1 nucleotide-binding domains. , Campbell JD , Proks P, Lippiat JD, Sansom MS, Ashcroft FM., Diabetes. December 1, 2004; 53 Suppl 3 S123-7.
Identification of the Xenopus laevis homolog of Saccharomyces cerevisiae DNA2 and its role in DNA replication. , Liu Q, Choe W, Campbell JL ., J Biol Chem. January 21, 2000; 275 (3): 1615-24.
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. , Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE , Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP., J Pharmacol Exp Ther. May 1, 1998; 285 (2): 777-86.
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. , Holladay MW, Wasicak JT, Lin NH, He Y, Ryther KB, Bannon AW, Buckley MJ, Kim DJ, Decker MW, Anderson DJ, Campbell JE , Kuntzweiler TA, Donnelly-Roberts DL, Piattoni-Kaplan M, Briggs CA, Williams M, Arneric SP., J Med Chem. February 12, 1998; 41 (4): 407-12.
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties. , Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Xue IC, Piattoni-Kaplan M, Molinari E, Campbell JE , McKenna DG, Gunn DE, Lin NH, Ryther KB, He Y, Holladay MW, Wonnacott S, Williams M, Arneric SP., J Pharmacol Exp Ther. October 1, 1997; 283 (1): 235-46.
A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand. , Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE , McKenna DG, Molinari E, Hettinger AM, Garvey DS, Wasicak JT, Holladay MW, Williams M, Arneric SP., Neuropharmacology. June 1, 1996; 35 (6): 725-34.
Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor. , Gopalakrishnan M, Buisson B, Touma E, Giordano T, Campbell JE , Hu IC, Donnelly-Roberts D, Arneric SP, Bertrand D, Sullivan JP., Eur J Pharmacol. August 15, 1995; 290 (3): 237-46.
Variations in differentiation in the regenerating lens of Xenopus laevis. , Campbell JC , Truman DE., Exp Eye Res. July 1, 1977; 25 (1): 99-100.
The subunit structure of chick lens crystallins and its relationship to their antigenic properties. , Truman DE, Clayton RM, Burns AT, Campbell JC ., Indian J Ophthalmol. June 1, 1972; 20 (2): 55-62.
Antigens of the lens of Xenopus laevis. , Campbell JC , Clayton RM, Truman DE., Exp Eye Res. January 1, 1968; 7 (1): 4-10.
The in vitro development of lens from cornea of larval Xenopus laevis. , Campbell JC , Jones KW., Dev Biol. January 1, 1968; 17 (1): 1-15.
AN IMMUNO-FLUORESCENT STUDY OF LENS REGENERATION IN LARVAL XENOPUS LAEVIS. , CAMPBELL JC ., J Embryol Exp Morphol. February 1, 1965; 13 171-9.